MIRATI THERAPEUTICS, INC. (NASDAQ:MRTX) Files An 8-K Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement

On April5, 2018, the Company entered into a Second Amendment to Lease Agreement (the “Amendment”) with ARE-SD Region No.20 (the “Landlord”) to amend the Lease Agreement, dated June24, 2014, and the First Amendment to Lease dated March23, 2017 (the “Amended Lease”) between the Company and Landlord. The Amendment extends the term of the Amended Lease for one year through January31, 2020. All other material terms and covenants from the Amended Lease remain unchanged.

A copy of the Amendment is filed as Exhibit 10.1 to this report and the description of the terms of the Amendment is qualified in its entirety by reference to such exhibit.

(d) Exhibits.

Mirati Therapeutics, Inc. Exhibit
EX-10.1 2 d541886dex101.htm EX-10.1 EX-10.1   [9393 Town Centre Drive/Mirati Therapeutics,…
To view the full exhibit click here